Medtronic plc (NYSE:MDT), a global leader in structural heart therapies, today announced U.S. Food and Drug Administration (FDA) approval of an early feasibility study (EFS) of the Intrepid Transcatheter Tricuspid Valve Replacement (TTVR) system in patients with severe, symptomatic tricuspid regurgitation, a disease in which the diseased, damaged or malfunctioning tricuspid valve allows blood to flow back into the hearts upper right chamber causing eventual heart failure or death. The study begins on the heels of a recent Breakthrough Device Designation issued by the FDA for the Intrepid TTVR System Continue reading →

New research shows that the novel coronavirus can essentially dice the muscle fibers of the human heart into pieces, sparking concerns about the potential for heart failure among Covid-19 survivors, Elizabeth Cooney reports for STAT News. Resources to support your CV telehealth strategy For the study, which was published preprint on bioRxiv and has not yet been peer reviewed, researchers added the new coronavirus, SARS-CoV-2, to three types of human heart cellscardiomyocytes, cardiac fibroblasts, and endothelial cellsthat were grown in lab dishes from stem cells. Only the cardiomyocytes, which are muscle cells, showed indication of viral infection that spread to other muscle cells, the researchers said Continue reading →

Oncomfort SA finalized a 10 million (US$11.8 million) series A fundraising round to further develop its Digital Sedation product and pursue international expansion. Debiopharm and Crdit Mutuel Innovation led the round with participation from Wallonia Innovation and Growth and previous investors. Digital Sedation uses virtual reality to deliver clinical hypnotherapy combined with integrative therapeutic techniques to relieve patients' pain and anxiety before, during and after medical procedures without medication Continue reading →

The Interventional Cardiology Market Report 2020 supplies a thorough opinion, clarify the segments on the industry scope and also the market enlarged insights and forecast by 2026. It shows market statistics according to industry drivers, restraints and chances, and examines the Interventional Cardiology industry status, the business share, size, prospective trends and growth rate of the market Continue reading →